Literature DB >> 16935473

Converting the prion protein: what makes the protein infectious.

Ilia V Baskakov1, Leonid Breydo.   

Abstract

The discovery of prion disease transmission in mammals, as well as a non-Mendelian type of inheritance in yeast, has led to the establishment of a new concept in biology, the prion hypothesis. The prion hypothesis postulates that an abnormal protein conformation propagates itself in an autocatalytic manner via recruitment of the normal isoform of the same protein as a substrate, and thereby acts either as a transmissible agent of disease (in mammals) or as a heritable determinant of phenotype (in yeast and fungus). Although reconstitution of fully infectious PrP(Sc)in vitro from synthetic components has not yet been achieved, numerous lines of evidence indicate that the prion protein is the major and essential component, if not the only one, of the prion infectious agent. This article summarizes our current knowledge about the chemical nature of the prion infectious agent, describes potential strategies and challenges related to the generation of prion infectivity de novo, proposes new hypotheses to explain the apparently low infectivity observed in the first synthetic mammalian prions, and describes plausible effects of chemical modifications on prion conversion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935473     DOI: 10.1016/j.bbadis.2006.07.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Distinct subregions of Swi1 manifest striking differences in prion transmission and SWI/SNF function.

Authors:  Zhiqiang Du; Emily T Crow; Hyun Seok Kang; Liming Li
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

3.  The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.

Authors:  Silvia Lisa; Massimiliano Meli; Gema Cabello; Ruth Gabizon; Giorgio Colombo; María Gasset
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

4.  Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.

Authors:  Ying Sun; Natallia Makarava; Cheng-I Lee; Pongpan Laksanalamai; Frank T Robb; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-01-03       Impact factor: 5.469

5.  Conformational switching within individual amyloid fibrils.

Authors:  Natallia Makarava; Valeriy G Ostapchenko; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

6.  The same primary structure of the prion protein yields two distinct self-propagating states.

Authors:  Natallia Makarava; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

Review 7.  Biology and Genetics of PrP Prion Strains.

Authors:  Sina Ghaemmaghami
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

8.  A new mechanism for transmissible prion diseases.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Valeriy G Ostapchenko; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 9.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 10.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.